• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[What is the value of tumor debulking and intraperitoneal cytostasis].

作者信息

Laffer U, Knüsli C, Harder F

机构信息

Department Chirurgie der Universität, Kantonsspital, Basel.

出版信息

Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1990:205-10.

PMID:1983552
Abstract

Local recurrences of intraperitoneal malignancies are mainly localized at the primary tumor site and the peritoneal surface. Surgical procedures alone are neither able to further reduce the development of local recurrence nor to treat the already established recurrent disease. In this situation intraperitoneal chemotherapy as an "adjuvant" treatment modality could be thought helpful. Experimental and clinical trials have shown that high doses of cytotoxic agents can be applied to the abdominal cavity with less systemic side effects. While the recent published data are not promising for gastrointestinal malignancies, they seem to be more encouraging for ovarian cancer.

摘要

相似文献

1
[What is the value of tumor debulking and intraperitoneal cytostasis].
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1990:205-10.
2
Peritoneal surface malignancies and regional treatment: a review of the literature.腹膜表面恶性肿瘤和区域治疗:文献回顾。
Surg Oncol. 2012 Jun;21(2):87-94. doi: 10.1016/j.suronc.2010.12.001. Epub 2011 Jan 8.
3
Intraperitoneal chemotherapy as treatment for ovarian carcinoma and gastrointestinal malignancies: the Memorial Sloan-Kettering Cancer Center experience).腹腔内化疗作为卵巢癌和胃肠道恶性肿瘤的治疗方法:纪念斯隆凯特琳癌症中心的经验
Acta Med Austriaca. 1989;16(3-4):65-7.
4
Adjuvant and neoadjuvant therapy for gastric cancer.胃癌的辅助治疗和新辅助治疗。
Semin Oncol. 1996 Jun;23(3):379-89.
5
A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.原发性胃癌切除术后辅助治疗的综述及大邱腹腔化疗Ⅲ期试验的最新进展。
Eur J Surg Oncol. 2006 Aug;32(6):655-60. doi: 10.1016/j.ejso.2006.03.010. Epub 2006 Apr 18.
6
[Toxicity results of an adjuvant study with intraperitoneal chemotherapy in patients with stomach cancer. Current status and future prospects of intraperitoneal therapy].[胃癌患者腹腔内化疗辅助研究的毒性结果。腹腔内治疗的现状与未来展望]
Wien Klin Wochenschr. 1987 Jun 12;99(12):415-20.
7
Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).经手术细胞减灭术和腹腔内热灌注化疗(HIPEC)治疗的多囊性及高分化乳头状腹膜间皮瘤。
Ann Surg Oncol. 2007 Oct;14(10):2790-7. doi: 10.1245/s10434-007-9475-8. Epub 2007 Jul 28.
8
[Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].[细胞减灭术及腹腔内热灌注化疗(HAPP)治疗腹膜癌病]
Minerva Chir. 2002 Oct;57(5):597-605.
9
Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients.细胞减灭术后腹腔内热灌注化疗治疗腹部肉瘤病:60例连续患者的临床结局及预后因素
Cancer. 2004 May 1;100(9):1943-50. doi: 10.1002/cncr.20192.
10
Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.对接受手术减瘤和腹腔内化疗的恶性腹膜间皮瘤患者预后相关因素的分析。
J Clin Oncol. 2003 Dec 15;21(24):4560-7. doi: 10.1200/JCO.2003.04.150.